Roivant Sciences Ltd. (ROIV) Discusses Phase 3 Results for Brepocitinib in Non-Infectious Uveitis Transcript

Roivant Sciences Ltd. (ROIV) Discusses Phase 3 Results for Brepocitinib in Non-Infectious Uveitis October 21, 2026 8:00 AM EDTCompany ParticipantsStephanie...

CryptoAlerta — análise de criptomoedas e mercado em tempo real